Comparison of the tear level between (-)-epigallocatechin gallate (EGCG) and (-)-epigallocatechin 3-O-(3-O-methyl) gallate (EGCG3"Me) after oral administration in healthy volunteers.
Not Applicable
- Conditions
- ot applicable
- Registration Number
- JPRN-UMIN000034291
- Lead Sponsor
- Department of Pharmacology Clinical Pharmacology, School of Medicine, Showa University, Clinical Research Institute for Clinical Pharmacology and Therapeutics
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
When an adverse event develops (including the accident). When we judge that a study responsibility physician or a study allotment physician should discontinue it. When a study is stopped on account of the subjects (moving, the pressure).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method